Recordati SpA (MIL:REC) Inventories, Finished Goods: €0 Mil (As of Mar. 2026)


MIL:REC Recordati SpA MIL:REC
94 GF Score
Price €51.35
GF Value €60.74
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Recordati SpA Inventories, Finished Goods?

Recordati SpA MIL:REC -0.48% 94 Inventories, Finished Goods is €0 Mil as of Mar. 2026. GuruFocus rates MIL:REC with a GF Score™ of 94/100 and a GF Value™ of €60.74 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Recordati SpA's quarterly finished goods increased from Sep. 2025 (€0 Mil) to Dec. 2025 (€280 Mil) but then declined from Dec. 2025 (€280 Mil) to Mar. 2026 (€0 Mil).

Recordati SpA's annual finished goods increased from Dec. 2023 (€233 Mil) to Dec. 2024 (€313 Mil) but then declined from Dec. 2024 (€313 Mil) to Dec. 2025 (€280 Mil).


Recordati SpA Inventories, Finished Goods Historical Data

* Premium members only.

The historical data trend for Recordati SpA's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Recordati SpA Inventories, Finished Goods Chart

Recordati SpA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Finished Goods
Get a 7-Day Free Trial Premium Member Only Premium Member Only 117.48 253.17 232.53 312.88 279.93

Recordati SpA Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 279.93 0.00
MIL:REC
94GF Score
Recordati SpA MIL:REC
Inventories, Finished Goods is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Recordati SpA Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

What does a Inventories, Finished Goods of €0 Mil mean?
Recordati SpA (MIL:REC) has a Inventories, Finished Goods of €0 Mil as of Mar. 2026. Finished goods are inventory items that are complete and ready to be sold. View historical data on Recordati SpA and its competitors.
Is Recordati SpA's Inventories, Finished Goods too high?
Recordati SpA's current Inventories, Finished Goods is €0 Mil. Overall, Recordati SpA has a GF Score™ of 94/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Recordati SpA's Inventories, Finished Goods compare to LLY and JNJ?
Recordati SpA's Inventories, Finished Goods of €0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Finished Goods for a Drug Manufacturers company?
A good Inventories, Finished Goods depends on the Drug Manufacturers industry context. However, Inventories, Finished Goods should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Finished Goods mean?
A high Inventories, Finished Goods can signal that a stock is expensive relative to its fundamentals. Finished goods are inventory items that are complete and ready to be sold. View historical data on Recordati SpA and its competitors. Recordati SpA's current Inventories, Finished Goods is €0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Recordati SpA stock overvalued right now?
Based on GuruFocus' analysis, Recordati SpA (MIL:REC) is currently considered Modestly Undervalued. The stock's GF Value™ is €60.74, compared to a current price of €51.35 — trading 15.5% below its estimated fair value. The current Inventories, Finished Goods is €0 Mil. Recordati SpA's overall GF Score™ is 94/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Finished Goods calculated?
Inventories, Finished Goods is calculated from a company's financial statements. For Recordati SpA (MIL:REC), the current Inventories, Finished Goods is €0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Recordati SpA (MIL:REC) Overvalued in 2026?

Based on GuruFocus' analysis, Recordati SpA stock appears to be undervalued. The current stock price of €51.35 is trading 15.5% below its estimated GF Value™ of €60.74. GuruFocus considers Recordati SpA to be Modestly Undervalued.

Key valuation signals for MIL:REC:

  • Inventories, Finished Goods: €0 Mil
  • GF Value™: €60.74 vs. price of €51.35 (15.5% below fair value)
  • GF Score™: 94/100 with 3 warning signs

No single metric tells the full story. See the MIL:REC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Recordati SpA Business Description

Address Via Matteo Civitali 1, MIlan, ITA, 20148
Recordati SpA is engaged in the development, production, and marketing of pharmaceutical products or of pharmaceutical chemicals. The Company operates in a broad and diverse context, which includes general medicine, specialist medicine, self-medication, and rare diseases. In addition, it is also active in the field of urology, with treatments for benign prostatic hyperplasia and male functional disorders, and in psychiatry. The Company's only operating segment is the Specialty & Primary Care segment. Its geographic areas are Europe, Australasia, America, and Africa.
94GF Score

Get the complete analysis for MIL:REC

Inventories, Finished Goods is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€51.35
Price
€60.74
GF Value